Abiopharma

News list

TCHELET RONEN 🟢 acquired 65.3K shares (1 derivative) of DYADIC INTERNATIONAL INC (DYAI) at $0.94 Transaction Date: Jan 02, 2026 | Filing ID: 000664

Full text

News bot Jan. 7, 2026, 12:26 a.m.
🔍 TCHELET RONEN (Executive)

Company: DYADIC INTERNATIONAL INC (DYAI)

Report Date: 2026-01-02
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 65,314
Detailed Transactions and Holdings:
- Acquired 18,064 shares of Common Stock (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 50,897.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 47,250 shares of Stock Option at $0.94 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 47,250.00 | transaction_form_type: 4 | Footnotes: F2, F3
Footnotes:
- F1: Represents common stock issued upon the vesting of RSUs. The RSUs were granted pursuant to the Issuer's key employee annual bonus, in lieu of a cash bonus earned for the year ended 2025. The RSUs vested in full upon grant.
- F2: Annual grant of stock options.
- F3: This option vests in one year, subject to continued service to the Issuer.